⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAT News
Phathom Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
PHAT
Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
PHAT
Form 8-K
sec.gov
PHAT
Phathom Pharmaceuticals Provides Update on FDA Litigation
globenewswire.com
PHAT
Form 8-K
sec.gov
PHAT
Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA
globenewswire.com
PHAT
Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
globenewswire.com
PHAT
Animal Biotechnology Market - Global Forecast 2026-2032 | AI, Genomics, Gene Editing, Vaccines, and Diagnostics Drive 8.68% CAGR Toward USD 60.56 Billion
globenewswire.com
BIO
ELAN
IMCC
IDXX
MRK
NEOG
PHAT
TMO
ZTS
Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA® (vonoprazan) at ACG 2026
globenewswire.com
PHAT
Phathom Pharmaceuticals to Present New Data and Analyses for VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting
globenewswire.com
PHAT